Femasys (FEMY) Notes Payables (2020 - 2025)

Femasys (FEMY) posted Notes Payables of $276489.0 for Q3 2025, down 95.45% on a QoQ basis from $6.1 million in Q2 2025.

Femasys (FEMY) Notes Payables (2020 - 2025) Analysis & Trends

Femasys' Notes Payables history runs 6 years deep, the most recent figure standing at $276489.0 for Q3 2025.

Quarterly Notes Payables changed N/A year-over-year to $276489.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $276489.0 (changed N/A YoY) and the FY2024 annual result came in at $5.4 million, changed N/A from the prior year.
Notes Payables was $276489.0 for Q3 2025 at Femasys, down from $6.1 million in the prior quarter.
Across five years, Notes Payables topped out at $6.1 million in Q2 2025 and bottomed at $45666.0 in Q1 2022.
A 5-year average of $1.6 million and a median of $302100.0 in 2021 frame the typical range for Notes Payables.
Annual changes were most pronounced in 2021 — Notes Payables tumbled 71.25% — and 2023, when it increased 0.98%.
Femasys' Notes Payables stood at $181123.0 in 2021, then slipped by 21.99% to $141298.0 in 2022, then surged by 100.52% to $283334.0 in 2023, then soared by 1808.08% to $5.4 million in 2024, then plunged by 94.89% to $276489.0 in 2025.
Business Quant data shows FEMY's Notes Payables at $276489.0 in Q3 2025, $6.1 million in Q2 2025, and $5.8 million in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn
10	Femasys	17.46 Mn	12.07 Mn	-

Download Data